These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 528079)

  • 1. Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum.
    Bartlett GL; Kreider JW
    Int J Cancer; 1979 Nov; 24(5):636-43. PubMed ID: 528079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corynebacterium parvum prevents immunization to admixed irradiated tumor cells by a local process.
    Titus MJ; Bartlett GL; Kreider JW
    Int J Cancer; 1982 Jun; 29(6):699-705. PubMed ID: 7107070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active specific immunotherapy of murine leukemia. I. Irradiated tumor cell vaccine.
    Bartlett GL; Kreider JW; Purnell DM
    Int J Cancer; 1979 Nov; 24(5):629-35. PubMed ID: 528078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of purified cell walls from Corynebacterium parvum.
    Riveros-Moreno V; Bomford R; Scott MT
    J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific T-lymphocyte cytotoxicity enhanced by low dose of C. parvum.
    Lau BH; Wang-Cheng RM; Tosk J
    J Leukoc Biol; 1987 May; 41(5):407-11. PubMed ID: 3494802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
    J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Corynebacterium parvum on murine myeloid leukaemia.
    Bjornsson S; Preisler H; Pavelic Z
    Br J Cancer; 1978 Dec; 38(6):703-8. PubMed ID: 217398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis.
    Bomford R; McHardy N
    Parasitology; 1979 Feb; 78(1):77-87. PubMed ID: 216967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor.
    Reif AE
    J Natl Cancer Inst; 1986 Oct; 77(4):899-908. PubMed ID: 3020300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B; Wolmark N; Saffer E; Fisher ER
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of immunopotentiators on tumors and tumor viruses.
    Morahan PS; Schuller GB; Snodgrass MJ; Kaplan AM
    J Infect Dis; 1976 Jun; 133 Suppl():A249-55. PubMed ID: 932503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.